Jubilant Cadista Pharmaceuticals Inc.
Pharmaceutical ManufacturingMaryland, United States201-500 Employees
Jubilant Cadista Pharmaceuticals Inc. is a pharmaceuticals company based out of 207 KILEY DR, Salisbury, Maryland, United States.
Growth Potential With a revenue range of $25 million to $50 million and a workforce of up to 500 employees, Jubilant Cadista Pharmaceuticals presents an emerging market opportunity for suppliers and service providers targeting mid-sized pharmaceutical manufacturers.
Product Focus Specializing in pharmaceutical manufacturing, the company offers opportunities for collaboration in raw materials, packaging, and manufacturing technology, especially as it expands its product portfolio.
Market Positioning As a regional player in Salisbury, Maryland, Jubilant Cadista can benefit from localized supply chain solutions and personalized customer engagement, making it a strategic partner for nearby health care providers and distributors.
Competitive Landscape Positioned among notable companies like Glenmark and Amneal with similar revenue scales, Jubilant Cadista can be targeted for niche partnerships, co-developments, and technology upgrades to strengthen its market presence.
Technology Adoption Given the competitive pharmaceutical manufacturing environment, there may be opportunities to introduce innovative manufacturing technologies or automation solutions to enhance efficiency and product quality.
| Jubilant Cadista Pharmaceuticals Inc. Email Formats | Percentage |
| First.Last@cadista.com | 95% |
| Last.First@cadista.com | 1% |
| FLast@cadista.com | 1% |
| FMiddleLast@cadista.com | 1% |
| Last@cadista.com | 1% |
| Last_First@cadista.com | 1% |
Pharmaceutical ManufacturingMaryland, United States201-500 Employees
Jubilant Cadista Pharmaceuticals Inc. is a pharmaceuticals company based out of 207 KILEY DR, Salisbury, Maryland, United States.
Jubilant Cadista Pharmaceuticals Inc.'s revenue is estimated to be in the range of $25M$50M
Jubilant Cadista Pharmaceuticals Inc.'s revenue is estimated to be in the range of $25M$50M